Morganna Freeman on Helping Patients Focus on Treatment Not Stigma

Video

Morganna Freeman, DO, FCAP, from The Angeles Clinic and Research Institute gives advice on how to help a patient who is dealing with the stigma associated with melanoma, or other cancers.

Morganna Freeman, DO, FCAP, from The Angeles Clinic and Research Institute gives advice on how to help a patient who is dealing with the stigma associated with melanoma, or other cancers.

Many patients with melanoma can feel guilty because of the stigma surrounding this cancer, similar to that with lung cancer. Freeman stresses a focus on moving forward, and making a plan of action. She also encourages nurses to recommend advocacy groups to their patients.

Recent Videos
woman in front of a blue background with dark hair
Related Content
Simple light blue line illustration of a lung with a tumor on a dark blue background

Zipalertinib Achieves ORR Primary Endpoint in NSCLC Study

Kyle Doherty
February 3rd 2025
Article

Zipalertinib demonstrated efficacy in pretreated NSCLC with EGFR exon 20 insertion mutations, meeting the primary endpoint of ORR in the REZILIENT1 study.

The Vitals

Nicole Gay Shares How She Counsels Patients on Lung Cancer Screenings

Lindsay Fischer
November 15th 2023
Podcast

Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.

dark blue background with a white outline indicating layers of skin

Cemiplimab as Adjuvant Therapy Improves DFS in High-Risk Cutaneous Squamous Cell Carcinoma

Caroline Seymour
January 20th 2025
Article

Adjuvant cemiplimab demonstrated a statistically significant improvement in DFS compared to placebo in post-surgical patients with high-risk CSCC, impacting post-operative care considerations.

The Vitals Podcast

Amber Pierce Underscores the Importance of 2-Step Verification With Relatlimab/Nivolumab

Lindsay Fischer
May 19th 2023
Podcast

Amber Pierce RN, BSN, OCN, highlights the importance of a 2-step verification process with fixed-dose regimen therapies.

yellow background with a white outline depicting lungs

Amivantamab/Lazertinib Improves Survival in EGFR+ Advanced Lung Cancer

Caroline Seymour
January 8th 2025
Article

Amivantamab and lazertinib improved overall survival compared to osimertinib as a first-line treatment for advanced or metastatic EGFR-mutant NSCLC.

light blue background with a white outline indicating lungs

Concurrent Chemoradiotherapy with SBRT Demonstrates Favorable Activity in NSCLC

Tim Cortese
January 7th 2025
Article

While the phase 2 trial did not meet its primary endpoint, it demonstrated that SBRT plus concurrent radiotherapy yielded better results than those observed in previous studies.